AGIOS PHARMACEUTICALS, INC. Balance Sheet
AGIO / Health Care|15 years of annual SEC 10-K data (FY2011-FY2025)
Shows total assets, cash and equivalents, receivables, property and equipment, total debt, and shareholders' equity across 15 fiscal years. All figures from audited SEC 10-K filings.
AGIOS PHARMACEUTICALS, INC. had $1.3B in total assets and $1.2B in shareholders' equity as of FY2025.
Based on SEC 10-K filings.
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score 3.83 (safe zone, above 2.9 threshold)
Data sourced from SEC EDGAR filings. Not investment advice.
| Item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | FY2015 | FY2014 | FY2013 | FY2012 | FY2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $89.1M | $76.2M | $88.2M | $139.3M | $203.1M | $127.4M | $80.9M | $70.5M | $102.7M | $160.8M | $71.6M | $14.0M | $71.6M | $91.3M | $117.7M |
| Inventory | $32.9M | $27.6M | $19.1M | $8.5M | $0 | - | $7.3M | $869.0K | $0 | - | - | - | - | - | - |
| Current Assets | $942.1M | $965.6M | $833.8M | $832.8M | $1.1B | $636.7M | $611.7M | $613.8M | $445.3M | $559.9M | $337.3M | $359.5M | $169.7M | $130.1M | - |
| PP&E (Net) | $10.8M | $11.7M | $15.4M | $23.0M | $28.9M | $32.3M | $31.5M | $24.3M | $24.4M | $25.3M | $23.2M | $6.4M | $3.8M | $3.6M | - |
| Total Assets | $1.3B | $1.7B | $937.1M | $1.2B | $1.4B | $853.0M | $890.7M | $858.5M | $614.4M | $619.1M | $420.1M | $491.9M | $201.2M | $137.0M | - |
| Current Liabilities | $82.2M | $81.2M | $68.0M | $62.6M | $59.8M | $94.4M | $92.9M | $93.5M | $94.9M | $88.4M | $52.9M | $61.1M | $36.9M | $35.1M | - |
| Shareholders' Equity | $1.2B | $1.5B | $811.0M | $1.1B | $1.3B | $399.5M | $640.5M | $687.5M | $375.5M | $358.6M | $131.5M | $424.4M | $131.5M | -$72.0M | -$52.8M |